A global strategic partnership to combat the rise of myopia in children has been announced by Hoya Vision Care and Haag-Streit.
The agreement enables their local partners, Device Technologies Australia and Toomac New Zealand, to provide eye care professionals with a seamless approach to myopia diagnosis and management using Lenstar Myopia by Hoya, and the corresponding EyeSuite myopia management software platform.
This technology provides information and education to patients and their parents about myopia and its’ progression. Combined with Hoya Vision Care’s easy-to-prescribe MiyoSmart spectacle lens, it creates a strong one-two approach to diagnose and manage myopia. The MiyoSmart spectacle lens uses revolutionary defocus incorporated multiple segments (D.I.M.S.) technology, which is clinically proven to slow down myopia progression, on average, by 60% in children ages 8-13.
“The strategic partnership with Haag- Streit aligns with one of Hoya Vision Care’s core missions to provide information and innovative solutions to our valued eye care professionals who are on the front lines as we globally address the rapidly growing problem of myopia in children,” said Alexandre Montague, CEO, Hoya Vision Care. “By bringing together our organisations’ technologies and solutions, we are creating a seamless approach for our eye care professional business partners to expand their myopia management capabilities and tackle this growing problem.”
Craig Chick, Managing Director of Hoya Vision Care Australia and New Zealand added, “With around one in four Australians and New Zealanders being myopic, and with this continuing to increase, we are very pleased to now be distributing Lenstar Myopia by Hoya to the market.”